EPISODE · Jul 14, 2023 · 37 MIN
Module 1 Week 4: Judicial Review results and evidential hearings continue (with Lorelei King & Enda McGarrity)
from The Covid Inquiry Podcast · host Broudie Jackson Canter
This week, Elkan is joined once again by Lorelei King, actress, screenwriter, narrator, and active member of the Covid-19 Bereaved Families for Justice group as well as Enda McGarrity from PA Duffy, who is one of the lead solicitors representing the Covid-19 Bereaved Families for Justice group Northern Ireland. Elkan, Lorelei and Enda discuss some of the key points that came out of week 4 of the hearings including dissecting more evidence from key witnesses. Be sure to subscribe to stay up to date with new weekly episodes of The Covid Inquiry Podcast. If you've lost a loved one to Covid-19, it isn't too late to be part of the Covid Inquiry. For more information on how to instruct legal representation, visit our website here: https://www.jacksonlees.co.uk/BroudieJacksonCanter/services/covid-inquiry
What this episode covers
This week, Elkan is joined once again by Lorelei King, actress, screenwriter, narrator, and active member of the Covid-19 Bereaved Families for Justice group as well as Enda McGarrity from PA Duffy, who is one of the lead solicitors representing the Covid-19 Bereaved Families for Justice group Northern Ireland. Elkan, Lorelei and Enda discuss some of the key points that came out of week 4 of the hearings including dissecting more evidence from key witnesses. Be sure to subscribe to stay up to date with new weekly episodes of The Covid Inquiry Podcast. If you've lost a loved one to Covid-19, it isn't too late to be part of the Covid Inquiry. For more information on how to instruct legal representation, visit our website here: https://www.jacksonlees.co.uk/BroudieJacksonCanter/services/covid-inquiry
NOW PLAYING
Module 1 Week 4: Judicial Review results and evidential hearings continue (with Lorelei King & Enda McGarrity)
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m